ePRO Risk Mitigation During the Coronavirus Disease 2019 (COVID-19) Pandemic

Celeste A. Elash, Director, eCOA Science On April 10, The Critical Path Institute (C-Path) released their presentation titled “Coronavirus Disease 2019 (COVID-19):  Risk Assessment and Mitigation Strategies for the Collection of Patient-Reported Outcome Data through Clinical Sites”.   This risk mitigation plan was a collaboration among C-Path, the Electronic Patient-Reported Outcome (ePRO) Consortium and the Patient-Reported…

YPrime Expands eCOA Offering for Remote Data Collection in Support of COVID-19 Clinical Trial Continuity

MALVERN, P.A., April 2, 2020 – As the spread of the COVID-19 pandemic continues to impact global clinical trial continuity and patient access to clinical care, YPrime today announced the release of web-based electronic clinical outcome assessments (eCOA) solutions to support remote data collection during challenging and uncertain times. “Site and patient-level considerations have been…